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Bloom syndrome is a disorder of profound and early cancer
predisposition in which cells become hypermutable, exhibit high
frequency of sister chromatid exchanges, and show increased
micronuclei. BLM, the gene mutated in Bloom syndrome, has been
cloned previously, and the BLM protein is a member of the RecQ
family of DNA helicases. Many lines of evidence suggest that BLM
is involved either directly in DNA replication or in surveillance
during DNA replication, but its specific roles remain unknown. Here
we show that hBLM can suppress both the temperature-sensitive
growth defect and the DNA damage sensitivity of the yeast DNA
replication mutant dna2-1. The dna2-1 mutant is defective in a
helicase-nuclease that is required either to coordinate with the
crucial Saccharomyces cerevisiae (sc) FEN1 nuclease in Okazaki
fragment maturation or to compensate for scFEN1 when its activity
is impaired. We show that human BLM interacts with both scDna2
and scFEN1 by using coimmunoprecipitation from yeast extracts,
suggesting that human BLM participates in the same steps of DNA
replication or repair as scFEN1 and scDna2.
Eukaryotic genomes encode hundreds of genes with homologyto DNA helicases. Many of these show functional overlap,
making it difficult to assign the precise DNA structures that are
unwound by the respective gene products during DNA replica-
tion, recombination, and repair. One class of human helicase, the
RecQ family, has received special attention in the past few years,
because mutations in three different RecQ helicase family
members give rise to three distinct human disorders leading to
cancer predisposition andor segmental premature aging, Bloom
syndrome, Werner syndrome, and Rothmund–Thomson syn-
drome (1–3). The genes affected in the diseases, BLM, WRN, and
RECQ4, have a single, sequence-specific homolog in yeast called
SGS1 (4, 5). Both hBLM and hWRN have been shown to be
biologically active in yeast by demonstrating the effects of their
expression on sgs1mutants. mWRN suppresses the slow-growth
phenotype and the inhibition of type II recombination at telo-
meres observed in est2sgs1 survivors (6). Both hBLM and
hWRN suppress the excessive illegitimate and homologous re-
combination phenotypes of sgs1 mutants (7). However, hBLM
and hWRN are not completely interchangeable in yeast. hBLM,
but not hWRN, restores slow growth in the sgs1top3 mutants
(7–10). Similarly, hBLM, but not hWRN, suppresses the prema-
ture aging phenotype of yeast sgs1 mutants (8). Differential
function in yeast is consistent with structural and biochemical
differences between BLM and WRN. BLM and WRN are
homologous mainly in the helicase domain but are divergent in
N-terminal and C-terminal domains. WRN, but not BLM, con-
tains an intrinsic nuclease activity in addition to helicase activity
(see ref. 2 for review). There are also clear differences in
physiological function, because the symptoms of Werner and
Bloom syndromes and types of cellular damage in humans differ.
Taken together, the sgs1 suppression studies clarify the function
of BLM and WRN by suggesting that they suppress recombina-
tion. Nevertheless, the suppression studies leave many questions
unanswered, because there are many mechanisms by which a
gene product might suppress recombination.
SGS1 interacts genetically with several other yeast helicase-
encoding genes, including the DNA2 helicase-nuclease identified
in our laboratory (11–13). Although Dna2 is not a member of the
RecQ helicase subfamily, and encodes both a nuclease and
helicase activity, sgs1dna2-2 mutants are synthetically lethal,
suggesting that their defects are synergistic (12, 14). DNA2 is
essential and is required for the elongation stage of DNA
replication in vivo and in vitro (11, 15–18). High-copy-number
suppression of the temperature-sensitive growth defect of a yeast
rad27 strain by DNA2 (and vice versa), synthetic lethality of the
dna2-1 allele with a rad27 mutation and with a DNA ligase
mutant, and biochemical evidence for an interaction between
Dna2 and the RAD27 gene product FEN1 suggest that Dna2 may
be involved in Okazaki fragment maturation (19–22). Interac-
tion of DNA2 with lagging strand-replication functions has also
been shown in Schizosaccharomyces pombe (23). A strand-
displacement model for removal of RNA primers during Oka-
zaki fragment processing was proposed that incorporated roles
for both FEN1 and Dna2 (24). In this model, pol  displaces the
RNA primer of the previously synthesized Okazaki fragment,
providing a flap structure that is endonucleolytically processed
by sequential action of Dna2 and FEN1 in preparation for
ligation (24). In vitro reconstitution of the processing reaction
showed that, if the flap was 30 nt, then Dna2 was required to
stimulate the endonucleolytic activity of FEN1; however, Dna2
had no effect if the flap was30 nt (24, 25). Thus, Dna2 is likely
to be essential for Okazaki fragment maturation only in cases
where FEN1 activity is somehow impaired (25, 26).
Dna2 is conserved in primary sequence from yeast to human
(23, 27, 28). In Xenopus, depletion of Xenopus laevis DNA2
(xDNA2) from egg extracts leads to inhibition of DNA replica-
tion, and Caenorhabditis elegans dna2 mutants appear to be
replication-deficient (29), so the function of Dna2 in DNA
replication is also conserved (27). The human genome contains
three genes related to DNA2 in the helicase domain, although
only one of them also shows conservation throughout the length
of the protein, including the nuclease domain (27, 28). Yeast
dna2 mutants are sensitive to x-rays, methyl methanesulfonate
(MMS), bleomycin, and hydroxyurea (HU) (15, 16). The mech-
anism by which Dna2 participates in base excision repair (MMS
sensitivity) may be related to its role in DNA replication, because
reconstitution of the repair reaction requires the same proteins
as those involved in Okazaki fragment maturation (26). Some
hypomorphic alleles of dna2 induce high levels of recombination
in the yeast rDNA, and yeast dna2 mutants have short lifespans
(12). Subnuclear localization of Saccharomyces cerevisiae (sc)
Dna2 in yeast is notable. The bulk of scDna2 is localized to
telomeres in the G1 and G2 phases of the cell cycle (16). The
scDna2 protein is released in S phase and is then found
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throughout the replicating chromatin. The scDna2 protein is also
released from telomeres by treatment of cells with agents that
cause DNA damage (16). The scDna2 relocalization from telo-
meres in response to DNA damage requires the checkpoint gene
MEC1 (unpublished data). All of these phenomena suggest that
scDna2 is a major suppressor of genome instability.
In this study, we show that both the human DNA2 and BLM
genes can suppress the temperature-sensitive growth and DNA
repair defects of dna2 mutants, suggesting that hBLM is involved
in DNA replication.
Materials and Methods
Strains. All of the strains used in this study were derived from
W303 (MATa ade2-1 can1-100 trp1-1 leu2-3,112 his3-11,15 ura3).
The dna2-1 derivative has been described (12). The rad27 and
BJ5459 strains have been described (15). Yeast cultures, trans-
formations, and other techniques were as described (30). All
media containing galactose also contained raffinose.
Plasmids and Constructs. hBLM was excised from pBluescript II
KS()-human (h) BLM (gift of Y. Furuichi, AGENE Research
Institute, Kanagawa, Japan) with NotIXhoI and inserted into
the yeast expression vector pRS316 behind the GAL promoter.
The helicase defective derivative was made by subcloning the
K695T mutation from pC4 BLM K695T (gift of N. Neff, New
York Blood Center, New York) on the EcoRISalI fragment
into the corresponding sites of the recipient plasmid. The
HindIIIXhoI fragment of pcDNA3-FLAG-mWRN and the
NotIXhoI fragment of pcDNA3-FLAG-hRecQ4 were cloned
into the corresponding sites of plasmid pRS316GAL, respec-
tively. (mWRN and hRECQ4 were obtained from Y. Furuichi.)
A hDNA2 (GenBank accession no. P51530) fragment containing
the complete ORF was cloned by PCR by using pBluescript II
SK()-hDNA2 (gift of N. Nobuo, Kazusa DNA Research
Institute, Chiba, Japan) as a template, and constructed as follows.
Based on the nucleotide sequence of the hDNA2 cDNA, a sense
primer, 5-CGGGATCCCGTCCAGGATGGAGCAGCTGA-
AC-3 (BamHI site underlined) and an antisense primer, 5-
CCGCTCGAGCGGTTACTTGTCATCGTCATCCTTGTA-
GTCTTCTCTTTGAAAGTCACCCAA-3 (XhoI site under-
lined) were used to amplify the complete ORF. The antisense
primer contains a stretch of 24 nt (boldface) that encodes a
FLAG tag in-frame to Glu-1060 of hDna2. The PCR fragment
was digested with BamHI and XhoI and inserted into the yeast
expression vector pRS316 behind the GAL promoter. pYEp24–
3a, containing the RAD27 gene on a YEp24-based vector,
pJDG-Rad27-myc, encoding scFEN1-myc, and pJDG-DNA2-
hemagglutinin (HA) have been described (15).
Measurement of MMS and HU Sensitivity. Overnight cultures were
diluted to an OD of 0.2 and grown for an additional 4–5 h.
Tenfold serial dilutions from each strain were spotted onto
synthetic complete plates containing galactose with or without
MMS (0.005%) or HU (150 mM). The plates were then incu-
bated for the time indicated. For each genotype tested, at least
two independent strains were assayed.
Protein Blotting. The dna2-1 cells transformed with pRS316,
pGAL-hBLM, or pGAL-hDNA2-FLAG were grown in SC
raffinose minus uracil (Ura) to an OD of 0.5, and the expression
was induced by adding 2% galactose. The cells were then
cultured for the time indicated, and extracts were prepared. The
cells, 0.5 ml of culture, were pelleted, washed, and resuspended
in 100 l of 50 mM NaOH (pH 10.5) containing 2 mM EDTA,
1 mM PMSF, 2% SDS, 10% glycerol, 5% mercaptoethanol, and
a mixture of protease inhibitors (Roche Molecular Biochemi-
cals), and boiled for 5 min. Debris was removed by centrifugation
and the supernatant was adjusted to pH 7.0 with 1 M HCl and
supplemented with bromophenol blue. Equal amounts of crude
lysates were electrophoresed in SDS7.5% polyacrylamide gels,
blotted to nitrocellulose membranes, and analyzed with mono-
clonal anti-FLAG M2 (Sigma) or polyclonal anti-BLM antibod-
ies (gift of N. Neff). scFen1-myc was detected by anti-myc (9E10,
Babco, Richmond, CA) antibodies. scDNA2-HA was detected
by anti-HA (12CA5, Roche Molecular Biochemicals) antibodies.
Secondary antibodies were purchased from Bio-Rad and de-
tected by using an ECL kit (Amersham Pharmacia) following the
manufacturer’s instructions.
Immunoprecipitation. Yeast cells were grown in yeast extract
peptoneraffinose (YPR) at 30°C until they reached an OD of
0.5, at which point 2% galactose was added. The cells were then
cultured for a further 4 h and pelleted by centrifugation. The
pellets were washed with sterile water twice, then resuspended
in 200 l of lysis buffer (50 mM TrisHCl, pH 7.6150 mM
NaCl0.2% Nonidet P-4010% glycerol15 mM DTT2 mM
EDTA1 mM PMSF, and a mixture of protease inhibitors).
Glass beads (500 l) were added, and the cells were lysed by
vortexing for 5 min. The extracts were clarified by 15 min of
centrifugation at 4°C. The supernatant was diluted with lysis
buffer and incubated at 4°C for 2 h with protein G-Sepharose
beads bound to anti-BLM or anti-myc antibodies or with protein
A-Sepharose beads bound to anti-HA antibodies. The beads
were washed four times with lysis buffer and boiled in sample
buffer, and the immunoprecipitates were resolved by SDS7.5%
PAGE.
Results
Suppression of Strain dna2-1. Because of the genetic interaction
between dna2 and sgs1, we tested whether any of the human
RecQ helicase disease genes could suppress any of the pheno-
types of dna2 mutants. The putative human DNA2 ORF, hDNA2
(28), the human BLM gene, hBLM (31), the murine FLAG-WRN
gene, mWRN (32), and the human FLAG-RECQ4 gene,
hRECQ4 (33), were each subcloned into the yeast single-copy,
centromeric vector pRS316 under the control of the GAL1,10
yeast promoter. As we had previously shown for the yeast DNA2
gene and the Xenopus DNA2 gene (xDNA2) (11, 27, 34), human
DNA2 (hDNA2) suppressed dna2-1 (Fig. 1A), suggesting that this
is the functional human Dna2 homolog. Suppression by xDNA2
is shown as a control. As shown in Fig. 1 A, hBLM also suppressed
the temperature-sensitive growth defect of a dna2-1 mutant.
Surprisingly, the complementation of yeast dna2-1 by hBLM is
as efficient as complementation by hDNA2 (Fig. 1 A). Suppres-
sion by hBLM required galactose induction. Western blotting
revealed that the hBLM protein was not expressed at detectable
levels on glucose medium (data not shown), but was present at
significant levels after 3 h of galactose induction (Fig. 1B). We
conclude that high levels of hBLM can function in yeast to
compensate for loss of dna2 function in DNA replication.
To ensure that the complementation was caused by the gene
introduced on the plasmid and not by chromosomal reversion or
suppression, the transformants were also tested on 5-fluoroo-
rotic acid (5-FOA) plates, on which only cells that have lost the
URA3 vector plasmid and have become Ura can grow. There
was no growth at 37°C on 5-FOA, indicating that suppression
requires the presence of the hBLM, hDNA2, and xDNA2 plas-
mid-encoded genes (Fig. 1C).
Neither mWRN nor hRECQ4 suppressed the temperature-
sensitive growth defect of a dna2-1 mutant (Figs. 1 A and 2C).
mWRN and hRECQ4 were expressed under these conditions of
induction, but at much lower levels than hBLM (data not shown).
Because mWRN and hRECQ4 were not expressed at high levels,
and because several attempts to improve expression were un-
successful, we can draw no conclusions at this time about their
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ability or inability to suppress dna2-1 replication defects. Thus,
the remainder of our studies address primarily hBLM.
Failure of hBLM(K695T) to Suppress Strain dna2-1. To explore the
mechanism of suppression by hBLM, a mutation that inactivates
the hBLM helicase, K695T (9), was expressed in the same way
in the dna2-1 strain. No complementation occurred at 37°C (Fig.
2A). Because the mutant hBLM and wild-type proteins were
expressed at similar levels (Fig. 2B), the helicase activity of
hBLM is essential to suppress the dna2-1 defect. We next
examined the complementation by a more quantitative dilution
assay. The suppression of yeast dna2-1 by hBLM is as efficient as
suppression by hDNA2, and the hBLM(K695T) mutant was
unable to suppress the dna2-1 defect at 37°C (Fig. 2C). A very
low level of viability (103) was restored to dna2-1 by
hBLM(K695T) at 35°C, which might be caused by stabilization of
partially active Dna2 protein by the helicase-dead hBLM protein
at the lower temperature (see below).
Suppression of HU and MMS Sensitivity of dna2-1 Mutants by hBLM.
dna2-1 mutants, like other dna2 mutants (15, 16), are sensitive
to MMS, a DNA alkylating agent, and HU, an inhibitor of
ribonucleotide reductase, even at the temperature permissive for
growth in the absence of drugs (Fig. 3). hDNA2 suppresses both
the MMS and HU sensitivity of dna2-1 at the permissive
temperature (Fig. 3). Wild-type hBLM also suppresses sensitivity
to 0.005% MMS (Fig. 3A) and 150 mM HU (Fig. 3B), but the
hBLM helicase mutant (K695T) does not. This finding demon-
strates that the ability of hBLM to act as a suppressor of dna2-1
is not uniquely specific for DNA replication, but also includes the
ability to suppress sensitivity to DNA-damaging agents. The low
level of MMS used here is thought to cause lethal damage during
S phase, because it induces the S-phase checkpoint (35). At
higher levels of MMS, even hDNA2 fails to complement the
damage sensitivity of dna2-1 mutants (data not shown). Both
mWRN and hRECQ4 expression caused increased sensitivity of
dna2-1 to MMS.
Lack of Suppression of Yeast rad27 by hBLM. hBLM might function
at either of two phases in the replication process to suppress the
growth defect of dna2-1 mutants. hBLM might reduce the need
for Dna2 during its otherwise essential role in fork propagation,
or hBLM might efficiently mediate repair of toxic structures
arising because of dna2 insufficiency. For instance, BLM has
been proposed to function in the resolution of regressed DNA
replication forks (see ref. 2 for review). If hBLM were involved
in repair of toxic intermediates, then hBLM might suppress
defects in mutants affecting proteins that participate in Okazaki
fragment processing along with scDNA2. As described in the
introduction, the essential function of DNA2 can be provided by
overproduction of scFEN1, and mutants lacking both FEN1 and
Dna2 are inviable, suggesting that they interact or perform
redundant functions in the same step of DNA replication.
scFEN1 is encoded by the RAD27 gene. rad27 mutants are
viable at 30°C, presumably because another protein can perform
a redundant function at this temperature, but rad27 mutants
are not viable at 37°C. We next asked if hBLM might also
suppress the temperature-sensitive growth of a rad27 strain. As
shown in Fig. 4A, hBLM does not suppress temperature-sensitive
growth of the rad27 mutant. rad27 mutants are also sensitive
to MMS. hBLM fails to suppress the MMS sensitivity of the
rad27 mutant at 30°C (Fig. 4B). We conclude that either the
damage in rad27 mutants is repaired by a different mechanism
than damage in dna2-1 mutants, or hBLM is specifically com-
pensating for Dna2 in propagating the yeast-replication fork.
Fig. 1. (A) hBLM and hDNA2 complement the dna2-1 temperature-sensitive phenotype. Strain dna2-1 was transformed with the following plasmids: empty
vector (pRS316), pGAL-hBLM, pGAL-FLAG-mWRN, pGAL-FLAG-hRecQ4, pGAL-hDNA2-FLAG, and pGAL-xDNA2. Transformants were streaked onto SC galactose
minus Ura and incubated at 23°C (Upper) and 37°C (Lower) for 10 days. (B) Analysis of expression levels for the hBLM and hDNA2 proteins in dna2-1 cells. Strains
dna2-1 transformed with empty vector (pRS316), pGAL-hBLM, and pGAL-hDNA2-FLAG were grown in SC galactose minus Ura and harvested at the indicated
times to prepare protein extracts. Extracts were prepared by the alkaline lysis method. Equal amounts of protein were loaded onto SDS7.5% PAGE and
immunoblots were probed with either anti-BLM (Upper) or anti-FLAG (Lower) antibodies. The positions of the hBLM and hDNA2 bands are indicated on the right.
(C) Strain dna2-1 carrying empty vector (pRS316), pGAL-hBLM, pGAL-hDNA2-FLAG, or pGAL-xDNA2 was streaked onto SC galactose minus Ura plates with (Right)
or without (Left) 5-FOA, and grown at 37°C for 7 days.








Physical Interaction Between hBLM and scFEN1 and Between hBLM
and scDna2. To obtain further evidence that hBLM is associated
with the replication fork, we wanted to show coimmunoprecipi-
tation of hBLM with a yeast-replication fork protein. We chose
scFEN1, because the human WRN helicasenuclease has been
shown to interact with FEN1 (36, 37), and the same might also
be true of hBLM, although it has not been reported. As shown
in Fig. 5A, we did find convincing coimmunoprecipitation of
hBLM and scFEN1-myc, which suggests that both scFEN1 and
hBLM reside in the same complex, although we cannot deter-
mine whether the interaction is direct or indirect. We also
examined the interaction of scFEN1-myc with the hBLM K695T
mutant protein, which did not complement the dna2-1 pheno-
types (Figs. 2 A and 3A). Similar to the wild-type hBLM, the
K695T mutant protein coprecipitated with scFEN1 (Fig. 5B).
Thus, we speculate that the K695T protein is present at the
replication fork but does not suppress dna2-1 phenotypes be-
cause it is catalytically inactive.
scFEN1 associates with the scDna2 helicasenuclease when
they are overexpressed (19). We therefore examined whether
hBLM interacts with scDna2. As shown in Fig. 5C, hBLM also
coimmunoprecipitates with scDna2-HA in extracts. These re-
sults suggest that hBLM participates in the same steps of DNA
replication or repair as scFEN1 and scDna2.
Discussion
In summary, expression of hBLM in dna2 mutants suppresses
both their replication and DNA repair defects, and with a similar
Fig. 2. The helicase activity of hBLM is required for complementation of
dna2-1. (A) hBLM helicase activity is required for complementation. The
dna2-1 cells carrying empty vector (pRS316), pGAL-hBLM, or pGAL-
hBLM(K695T) were streaked onto SC galactose minus Ura plates and grown at
23°C or 37°C for 7 days. The K695T mutation changes lysine to arginine at
amino acid position 695 within the helicase domain of hBLM. (B) Expression of
hBLM(K695T). Strain dna2-1 transformed with various vectors were analyzed
by Western blotting with anti-hBLM antibody as described in Fig. 1B. Lane Vec,
dna2-1 transformed with empty vector (pRS316); lane BLM, pGAL-hBLM; lane
K695T, pGAL-hBLM(K695T). The position of hBLM is indicated. The helicase
mutant protein always migrates slightly more slowly than the wild-type
protein, as noted (9). (C) Complementation assay at different temperatures.
Exponentially growing yeast cultures of dna2-1 cells carrying empty vector
(pRS316), pGAL-hBLM, pGAL-hBLM(K695T), pGAL-FLAG-mWRN, pGAL-FLAG-
hRecQ4, and pGAL-hDNA2-FLAG were spotted in 10-fold serial dilutions onto
SC glucose minus Ura or SC galactose minus Ura plates and grown at 23°C,
35°C, and 37°C for 5–7 days.
Fig. 3. Complementation of sensitivity of dna2-1 to MMS and HU. Exponen-
tially growing yeast cultures of wild-type cells carrying empty vector (pRS316)
and dna2-1 cells carrying empty vector, pGAL-hBLM, pGAL-hBLM(K695T),
pGAL-FLAG-mWRN, pGAL-FLAG-RecQ4, and pGAL-hDNA2-FLAG were spot-
ted in 10-fold serial dilutions onto SC galactose minus Ura plates with or
without MMS or HU at the concentrations indicated and grown at the per-
missive temperature for 6 days. This experiment was performed in duplicate
with identical results.
Fig. 4. Lack of complementation of temperature-sensitive growth and MMS
sensitivity of strain rad27. Exponentially growing yeast cultures of W303 wild
type, rad27, rad27vector, rad27pGAL-hBLM, and rad27Yep24-Rad27
were spotted in 10-fold serial dilution onto plates. (A) Growth at 30°C or 37°C.
(B) Growth in the presence and absence of 0.005% MMS. Cells were grown for
3 days.
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efficiency to hDNA2. hBLM does not suppress rad27 mutants,
however, suggesting that hBLM is specifically suppressing dna2
defects. This finding suggests that hBLM may be at the replica-
tion fork, and, supporting this, hBLM coimmunoprecipitates
with scFEN1 and scDna2. This result forges a direct link between
hBLM and the replication apparatus. Similarly, depletion of
xBLM from Xenopus in vitro replication extracts suggests
that xBLM is involved in DNA replication (38).
Suppression of the dna2-1 temperature-sensitive growth and
repair defect by hBLM helicase is intriguing. The question arises
whether hBLM can functionally substitute for scDna2 protein or
if the role of the hBLM protein is indirect, involving additional
molecular transactions leading to genomic stability of the dna2
strain. The Dna2 and BLM helicases have opposite direction-
alities on simple duplex substrate DNAs (39, 40). This finding
alone may suggest that the suppression is not caused by direct
replacement of Dna2 activities. Because scDna2 and hBLM
interact, one form of indirect suppression might be stimulation
or stabilization of scDna2 activities. Several lines of evidence
involving BLM, WRN, and FEN1 proteins may provide addi-
tional clues as to the function of BLM in suppression of the dna2
defect. (i) We have demonstrated that overproduction of
scFEN1 nuclease suppresses the dna2-1 defect (19). (ii) We have
shown that hBLM and scFEN1 interact physically. (iii) WRN and
FEN1 interact and the interaction enhances FEN1 cleavage
activity (36). (iv) hBLM is thought to recruit several repair
checkpoint proteins to arrested replication forks (41, 42). There-
fore, it is conceivable that the hBLMscFEN1 interaction at the
replication fork leads to either enhanced cleavage by scFEN1 or
enhanced recruitment of scFEN1 to the flap, effectively raising
the local concentration of the protein and reducing the need for
scDna2. Suggesting that some component of the maturation
system, such as a helicase, may be missing in vitro, pol  cannot
strand displace rapidly enough in a reconstituted model system
containing purified pol , proliferating cell nuclear antigen,
RFC, FEN1, Dna2, and ligase to account for rates of Okazaki
fragment maturation in vivo (25, 26). Thus, hBLM might stim-
ulate flap formation. By stimulating scFEN1 in these or in other
ways, hBLM might offset the need for full scDna2 activity. Yeast
rad27sgs1 double mutants are inviable, suggesting a similar
possible role for the yeast hBLM homolog Sgs1 helicase (43).
Fibroblasts from patients with Bloom syndrome show a retarded
rate of DNA chain growth that might be explained by a model
in which BLM is essential for efficient Dna2FEN1-mediated
maturation of replication intermediates (44, 45).
It has recently been suggested that an important function of
hBLM and its yeast ortholog, Sgs1, may be to aid the replisome
in copying DNA sequences that form alternative structures
(46, 47). Both hBLM and Sgs1 proteins were shown to have
significantly greater affinity for G quartet DNA and more
rapid kinetics of unwinding of G DNA than of Holliday
junctions (47). Dna2 helicase might perform a similar function,
in addition to or instead of its proposed role in Okazaki
fragment processing, which might account for the suppression
Fig. 5. Interaction between hBLM and replication fork proteins. (A) Interaction between hBLM and scFEN1. Extracts from BJ5459 transformed with pGAL-hBLM,
pJDG-Rad27-myc encoding scFEN1-myc, or both were prepared, and immunoprecipitations were performed with either anti-myc (Upper) or anti-BLM (Lower)
antibodies. Washed immunoprecipitates were loaded onto SDS7.5% PAGE and immunoblotted with either anti-BLM or anti-myc antibodies, as indicated. (B)
Interaction of the hBLM(K695T) mutant protein with scFEN1. Extracts were prepared from BJ5459 cells carrying pJDG-Rad27-myc and pGAL-hBLM or
pGAL-BLM(K695T) and subjected to immunoprecipitation with anti-myc antibodies. The immunoprecipitates were immunoblotted with either anti-BLM or
anti-myc antibodies, as indicated. BLM(K695T) always migrates slightly more slowly than wild-type BLM protein (see also Fig. 2B). (C) Interaction of hBLM with
scDNA2. Extracts were prepared from BJ5459 cells carrying pGAL-hBLM and pJDG-DNA2-HA and subjected to immunoprecipitation with anti-HA antibodies. The
immunoprecipitates were immunoblotted with either anti-BLM or anti-HA antibodies, as indicated. WCE, whole-cell extract before immunoprecipitation; IP,
immunoprecipitationimmunoprecipitate; WB, Western blot of immunoprecipitate;, control with no antibody in IP mix;, presence of indicated antibody in
IP mix.








of dna2-1 by hBLM and the synthetic lethality of sgs1 and
dna2-2. dna2-2 mutants show increased pausing in the ribo-
somal DNA (48), and Dna2 is localized to telomeres and
participates in their stable maintenance (13). Both of these
DNA regions have G-rich repeats. hBLM has also recently
been linked to telomere function in several studies (49, 50).
Taken together, we conclude that BLM plays an important role
in DNA replication and repair, possibly directly, or, alterna-
tively, as a molecular matchmaker at a crossroad between
DNA replication and repair.
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